Neutrophil‐Derived Biomimetic Nanoreactors Reprogram the Mitochondrial Metabolism‐Inflammation Axis to Alleviate Hepatic Ischemia‐Reperfusion Injury
ABSTRACT Hepatic ischemia‐reperfusion injury (IRI) is a major cause of postoperative liver dysfunction after hepatectomy and liver transplantation; however, effective targeted therapies are unavailable. Here, we developed a biomimetic nanoplatform, Curcumin@CeO 2 @ZIF‐8@N2 neutrophil‐derived cellular vesicles (CCZ@N2‐CVs), for targeted and multimodal protection against hepatic IRI. ZIF‐8 enables acid‐responsive curcumin release and localized Zn 2 + delivery within the injury microenvironment, and CeO 2 provides sustained antioxidant activity via Ce 3 + /Ce 4 + redox cycling. Surface coating with N2 neutrophil‐derived vesicles endows the nanoplatform with inflammation‐targeting capabilities and intrinsic immunomodulatory properties. In hepatocytes subjected to hypoxia‐reoxygenation, CCZ@N2‐CVs markedly attenuate oxidative stress, inflammatory cytokine production, and apoptosis, and restore mitochondrial membrane potential, respiratory function, and ATP generation. Moreover, the platform suppresses pro‐inflammatory macrophage polarization and promotes a reparative phenotype, thereby enhancing hepatocyte proliferation and migration. In a rat hepatic IRI model, intravenously administered CCZ@N2‐CVs preferentially accumulate in the liver and significantly mitigate tissue injury, as evidenced by reduced serum alanine aminotransferase and aspartate aminotransferase levels, decreased apoptosis, and improved histopathological outcomes. Enhanced mitochondrial metabolism and suppressed inflammatory pathways are observed in a transcriptomic analysis. Furthermore, CCZ@N2‐CVs demonstrate favorable biosafety. Collectively, this biomimetic platform exhibits ion‐mediated therapeutic nanozyme activity and establishes targeted delivery to achieve multi‐mechanistic protection against hepatic IRI.
Authors
- Zhijin Fan (ORCID: https://orcid.org/0000-0003-0018-4949)
- Xianwen Wang (ORCID: https://orcid.org/0000-0002-6343-440X)
- Quanshi Lin
- Renguo Guan (ORCID: https://orcid.org/0000-0002-9487-7369)
- Pu Shen
- Ye Lin (ORCID: https://orcid.org/0000-0001-6472-6714)
- Mingbin Zhan
- Kaijun Huang
- Shuting Xie
- Haoxiang Yuan
Institutions
- Anhui Medical University (CN)
- Kunming Medical University (CN)
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Guangdong Provincial People's Hospital (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Advanced Science
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1002/advs.78722
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China